framycetin has been researched along with Obesity in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Devi, LA; Fakira, AK; Fricker, LD; Hochgeschwender, U; Jeltyi, A; Lemos Duarte, M; Lueptow, L; Tashima, AK; Wetsel, WC | 1 |
| Adeshirlarijaney, A; Chassaing, B; Gewirtz, AT; Tran, HQ; Zou, J | 1 |
| Chaix, A; Chang, MW; Knight, R; Marotz, CA; Panda, S; Saghatelian, A; Xu, ZZ; Zarrinpar, A | 1 |
| Bomhof, MR; Eller, LK; Geuking, MB; Paul, HA; Reimer, RA | 1 |
| Dharmsathaphorn, K; Hofmann, AF; Laker, MF; Lorenzo, D; Sherr, HP | 1 |
| Cope, K; Diehl, AM; Risby, T | 1 |
| Arnot, RS; Evans, M; Leaper, DJ; Pollock, AV | 1 |
| O'Leary, JP; Parker, TH | 1 |
| Meares, EM | 1 |
| Parker, F | 1 |
| Faloon, WW; Lim, EC; Rubulis, A; Schwob, D; Sherman, CD | 1 |
| Lewis, B | 1 |
| Faloon, WW; Rubert, M; Rubulis, A | 1 |
| Mandell, AJ; Rubin, RT | 1 |
2 review(s) available for framycetin and Obesity
| Article | Year |
|---|---|
Factors that influence surgical wound infections. Role of prophylactic antibiotic therapy.
Topics: Age Factors; Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephaloridine; Diabetes Complications; Drainage; Gloves, Surgical; Guinea Pigs; Hexachlorophene; Humans; Intestines; Kanamycin; Length of Stay; Neomycin; Nutrition Disorders; Obesity; Penicillins; Staphylococcal Infections; Surgical Wound Infection; Ultraviolet Rays | 1975 |
Malabsorption due to neomycin.
Topics: Glycoside Hydrolases; Humans; Intestinal Absorption; Intestines; Malabsorption Syndromes; Neomycin; Obesity | 1969 |
1 trial(s) available for framycetin and Obesity
| Article | Year |
|---|---|
The role of antibacterial preparation of the intestine in the reduction of primary wound sepsis after operations on the colon and rectum.
Topics: Anti-Bacterial Agents; Bacteria; Cephaloridine; Colon; Drug Therapy, Combination; Female; Humans; Male; Neomycin; Obesity; Preoperative Care; Rectum; Sulfathiazoles; Surgical Wound Infection; Tetracycline | 1978 |
12 other study(ies) available for framycetin and Obesity
| Article | Year |
|---|---|
Mice heterozygous for a null mutation of CPE show reduced expression of carboxypeptidase e mRNA and enzyme activity but normal physiology, behavior, and levels of neuropeptides.
Topics: Animals; Behavior, Animal; Carboxypeptidase H; Loss of Function Mutation; Mice; Mice, Knockout; Neomycin; Neuropeptides; Obesity; RNA, Messenger | 2022 |
Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Diet, High-Fat; Fatty Liver; Gastrointestinal Microbiome; Germ-Free Life; Hyperglycemia; Hypoglycemic Agents; Inflammation; Liver; Metabolic Syndrome; Metformin; Mice; Neomycin; Obesity | 2019 |
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Blood Glucose; Body Composition; Body Weight; Cecum; Colon; Fatty Acids, Volatile; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Homeostasis; Insulin; Insulin Resistance; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neomycin; Obesity; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Improvement in adiposity with oligofructose is modified by antibiotics in obese rats.
Topics: Adiposity; Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Blood Glucose; Energy Intake; Glucose Tolerance Test; Male; Neomycin; Obesity; Oligosaccharides; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 16S | 2016 |
Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery. Oxalogenic substances in diet contribute to urinary oxalate.
Topics: Adult; Colon; Diet; Dietary Proteins; Female; Humans; Ileum; Intestinal Absorption; Intestines; Jejunum; Male; Middle Aged; Neomycin; Obesity; Oxalates; Oxalic Acid | 1983 |
Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis.
Topics: Administration, Oral; Aging; Animals; Anti-Bacterial Agents; Body Weight; Breath Tests; Circadian Rhythm; Digestive System; Ethanol; Fatty Liver; Male; Mice; Mice, Inbred C57BL; Neomycin; Obesity; Reference Values | 2000 |
Effect of preparation of the small intestine on microflora and postoperative wound infection.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ileum; Intestine, Small; Jejunum; Neomycin; Obesity; Retrospective Studies; Surgical Wound Infection | 1978 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |
Effects of neomycin in obese patients with jejunoileostomy.
Topics: Administration, Oral; Adult; Bile Acids and Salts; Body Weight; Carotenoids; Cholesterol; Feces; Female; Humans; Ileostomy; Intestinal Absorption; Jejunum; Lipid Metabolism; Malabsorption Syndromes; Middle Aged; Neomycin; Obesity; Sterols; Triglycerides | 1972 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Metabolic Clearance Rate; Neomycin; Nicotinic Acids; Obesity; Oxymetholone; Triglycerides | 1971 |
Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine.
Topics: Administration, Oral; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Colchicine; Feces; Gastrointestinal Diseases; Humans; Neomycin; Obesity; Sterols | 1970 |
Indolylacroyl glycine excretion in man.
Topics: Acrylates; Chromatography, Paper; Glycine; Humans; In Vitro Techniques; Indoles; Infrared Rays; Mental Disorders; Neomycin; Obesity; Spectrophotometry; Urine | 1965 |